$150MSeries C, 16 October 2025
Run multiple Phase 3 trials of VDPHL01 and prepare an NDA
- Amount
- $150M
- Stage
- Series C
- Announced
- 16 October 2025
- Lead
- SR One
- Other investors
- Viking Global Investors, Marshall Wace, Invus, Longitude Capital, Surveyor Capital
- Use of funds
- Run multiple Phase 3 trials of VDPHL01 and prepare an NDA
- Checked
- Announced by the company
- Sources
- Veradermics raises $150M Series C (date approx) businesswire.com
Veradermics raises $150M Series C (date approx) alleywatch.com